The latest company infringing on MCETs patent to come to the Market.
Clonetech, Takara bio new to the market as of 2-26-2021
TAKAERA BIO WEBSITE:
What's new
Takara Bio USA, Inc. elevates the sensitivity of scRNA-seq in its continuing mission to support the efforts of single-cell researcher
Takara Bio USA, Inc. continues to provide researchers improved sensitivity and performance for single-cell analysis with the launch of our recent next-generation sequencing product, SMART-Seq Single Cell Kit.
01/26/2021
takarabio.com
News
Clontech Laboratories & TET Systems Announce the Broadening of Their License Agreement
Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., and TET Systems, a privately-held German biotech company based in Heidelberg, announced that they have signed an amendment to their existing license agreement. Under the expanded license agreement, Clontech obtains r ... more
Article
An Immortalized Hepatocyte-Like Cell Line (imHC) Accommodated Complete Viral Lifecycle, Viral Persistence Form, cccDNA and Eventual Spreading of a Clinically-Isolated HBV
Khanit Sa-ngiamsuntorn, Piyanoot Thongsri, [...], and Suradej Hongeng
Additional article information
ncbi.nlm.nih.gov
2.3. Production of HBV from Cultured Cells
Cell culture based hepatitis B virus (HBVcc subtype adw2) was prepared from freshly collected supernatants of the HBV stably transfected HepG2 cell line, clone 2.2.15 [22]. HepG2.2.15 cells were maintained in DMEM (Hyclone, GE Healthcare), 10% FBS, 100 U/mL penicillin, 100 µg/mL streptomycin. The supernatant was collected at 7 d after adding 380 µg/mL G418 and concentrated 100-fold. The collected supernatants were filtered through 0.45 µm and viral particles were concentrated by Lenti-X™ Concentrator (Clonetech, Takara Bio, Mountain View, CA, USA). The mixtures were incubated at 4 °C at least 30 min before centrifugation at 1500× g for 45 min at 4 °C following the manufacturer’s instructions.
Check out Multicell Technology Inc Patent.
Google Patent:
patents.google.com |
